Group 1 - The company, Bluestar Medical, disclosed a tax payment and interest totaling approximately 196 million yuan that needs to be repaid [2][3] - The tax adjustment relates to transfer pricing issues concerning cross-border related party transactions from 2020 to 2022 [2] - The company is expected to report a net loss attributable to shareholders ranging from 650 million yuan to 850 million yuan for 2025, indicating an increase in losses compared to 2024 [4] Group 2 - Bluestar Medical is headquartered in Zibo, Shandong, and its main business areas include cardiovascular medical consumables, health protection gloves, and emergency rescue kits [3] - The total amount of tax and interest that Bluestar Medical and its subsidiaries need to repay is approximately 195.86 million yuan as of December 31, 2025 [3]